Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients.

Jonathan M Meyer,Adam Simmons,Ying Jiang,Christine Graham,Sergey Yagoda,David McDonnell

CNS spectrums（2022）

引用 2|浏览5

暂无评分

摘要

In these exploratory subgroup analyses from the ENLIGHTEN-2 study, weight-mitigating effects of OLZ/SAM vs olanzapine were observed consistently across patient subgroups and were in line with results from the overall study population.

查看译文

关键词

Antipsychotic,Lybalvi,body mass index,body weight,clinical trial,outpatients,schizophrenia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要